These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32314492)

  • 1. Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak.
    Conforti C; Giuffrida R; Zalaudek I; Di Meo N
    Dermatol Ther; 2020 Jul; 33(4):e13437. PubMed ID: 32314492
    [No Abstract]   [Full Text] [Related]  

  • 2. How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.
    Ledford H
    Nature; 2020 Apr; 580(7803):311-312. PubMed ID: 32273618
    [No Abstract]   [Full Text] [Related]  

  • 3. Surviving the storm: Dealing with COVID-19.
    Vandenbark AA; Meza-Romero R; Offner H
    Cell Immunol; 2020 Aug; 354():104153. PubMed ID: 32563849
    [No Abstract]   [Full Text] [Related]  

  • 4. A potential treatment of COVID-19 with TGF-β blockade.
    Chen W
    Int J Biol Sci; 2020; 16(11):1954-1955. PubMed ID: 32398962
    [No Abstract]   [Full Text] [Related]  

  • 5. Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19.
    Ghaffari S; Roshanravan N; Tutunchi H; Ostadrahimi A; Pouraghaei M; Kafil B
    Arch Med Res; 2020 Jul; 51(5):464-467. PubMed ID: 32327293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we unstress SARS-CoV-2 infected cells?
    Csukasi F; Rico G; Becerra J; Duran I
    Cytokine Growth Factor Rev; 2020 Aug; 54():3-5. PubMed ID: 32563554
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 as a cause of immune thrombocytopenia.
    Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
    Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
    [No Abstract]   [Full Text] [Related]  

  • 10. [Not Available].
    Balavoine JF
    Rev Med Suisse; 2020 May; 16(695):1126. PubMed ID: 32462848
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
    Menegazzi M; Campagnari R; Bertoldi M; Crupi R; Di Paola R; Cuzzocrea S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
    Nasiripour S; Zamani F; Farasatinasab M
    J Clin Pharmacol; 2020 Jul; 60(7):828-829. PubMed ID: 32445400
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!
    Lazzerini PE; Boutjdir M; Capecchi PL
    Circulation; 2020 Jul; 142(1):7-9. PubMed ID: 32286863
    [No Abstract]   [Full Text] [Related]  

  • 14. Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis.
    Tong TRS
    Infect Disord Drug Targets; 2020; 20(3):351. PubMed ID: 32696730
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
    Theoharides TC
    Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune status could determine efficacy of COVID-19 therapies.
    Cully M
    Nat Rev Drug Discov; 2020 Jul; 19(7):431-434. PubMed ID: 32546768
    [No Abstract]   [Full Text] [Related]  

  • 17. Pros and cons of corticosteroid therapy for COVID-19 patients.
    Mattos-Silva P; Felix NS; Silva PL; Robba C; Battaglini D; Pelosi P; Rocco PRM; Cruz FF
    Respir Physiol Neurobiol; 2020 Sep; 280():103492. PubMed ID: 32659271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
    van den Berg DF; Te Velde AA
    Front Immunol; 2020; 11():1580. PubMed ID: 32670297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of methylprednisolone for treating severe COVID-19.
    Liu J; Zheng X; Huang Y; Shan H; Huang J
    J Allergy Clin Immunol; 2020 Aug; 146(2):325-327. PubMed ID: 32479759
    [No Abstract]   [Full Text] [Related]  

  • 20. Audio Interview: Acute Lung Injury in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(2):e32. PubMed ID: 32640146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.